MediSync Clinical Research is a clinical research site located in Petal, Mississippi, United States 39465.
Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.
MediSync Clinical Research has participated in 4 clinical trials.
Therapeutic areas: Type 2 Diabetes, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention.
Sponsors: Eli Lilly and Company, Janssen Vaccines & Prevention B.V., Janssen Research & Development, LLC.
Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MediSync Clinical Research has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MediSync Clinical Research has 4 clinical trials on record. Their work covers Type 2 Diabetes, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention.
MediSync Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.